Abstract Title:

[Central pathology review. Inclusion criterion for clinical studies of ovarian carcinomas?].

Abstract Source:

Pathologe. 2008 Nov ;29 Suppl 2:157-9. PMID: 18726596

Abstract Author(s):

F Kommoss, S Kommoss, D Schmidt, A du Bois, J Pfisterer

Article Affiliation:

F Kommoss


Currently histopathological review is not standard practice in clinical studies of ovarian carcinomas. Published retrospective analyses as well as own unpublished observations have indicated that a certain percentage of study patients may have ovarian lesions other than ovarian carcinomas which may be in conflict with study inclusion criteria. In this context, the distinction of ovarian carcinomas from borderline tumors, ovarian metastases, and sex cord tumors has been shown to be a potential pitfall. In cases of incorrect diagnoses, non-beneficial morbidity at unnecessary high cost may occur, in other instances, more adequate therapeutic modalities might be withheld from a patient. At present, the concept of a central histopathology review for patients with ovarian carcinomas is being studied prospectively in a translational research project of the AGO-Ovar termed"HIstologische STandardisierte Zweitbegutachtung in einem Studienkollektiv fortgeschrittener Ovarialkarzinome, OVAR 11t-HISTO"(Histological standardized review in a study collective of advanced ovarian cancer; http://www.mh-hannover.de/institute/pathologie/dgp:Studien).

Study Type : Review

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.